WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2002002519) THROMBIN OR FACTOR Xa INHIBITORS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2002/002519    International Application No.:    PCT/US2001/020962
Publication Date: 10.01.2002 International Filing Date: 29.06.2001
Chapter 2 Demand Filed:    15.01.2002    
IPC:
C07D 207/09 (2006.01), C07D 207/273 (2006.01), C07D 213/64 (2006.01), C07D 213/73 (2006.01), C07D 241/18 (2006.01), C07D 295/192 (2006.01), C07D 295/26 (2006.01), C07D 401/06 (2006.01), C07D 471/04 (2006.01), C07D 487/04 (2006.01), C07D 517/04 (2006.01)
Applicants: BRISTOL-MYERS SQUIBB PHARMA COMPANY [US/US]; Patent Dept., P.O. Box 4000, Princeton, NJ 08543-4000 (US)
Inventors: PINTO, Donald, J., P.; (US).
QUAN, Mimi, L.; (US)
Agent: BELFIELD, Jing, S.; Bristol-Myers Squibb Pharma Company, Route 141 & Henry Clay Road, Experimental Station, E353/133B, Wilmington, DE 19898-0353 (US)
Priority Data:
60/214,831 29.06.2000 US
Title (EN) THROMBIN OR FACTOR Xa INHIBITORS
(FR) INHIBITEURS DE LA THROMBINE OU DU FACTEUR XA
Abstract: front page image
(EN)This invention relates generally to heteroaryl-phenyl substituted compounds that are inhibitors of trypsin-like serine protease enzymes, especially factor Xa or thrombin, pharmaceutical compositions containing the same, and methods of using the same as anticoagulant agents for treatment and prevention of thromboembolic disorders.
(FR)Cette invention se rapporte d'une façon générale à des composés à substitution hétéroaryle-phényle, qui constituent des inhibiteurs des enzymes sérine-protéases de type trypsine, en particulier le facteur Xa ou la thrombine, à des compositions pharmaceutiques contenant ces composés, et à des procédés d'utilisation de ceux-ci comme agents anticoagulants dans le traitement et la prévention des affections thromboemboliques.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CR, CU, CZ, DE, DK, DM, DZ, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)